Preview

Biomedical Photonics

Advanced search

New approaches to formation of diagnosis-related groups for payment for radiotherapy and chemoradiotherapy based on clinical guidelines with the use of standardized modules of healthcare

https://doi.org/10.24931/2413-9432-2019-8-4-36-46

Abstract

The article presents a methodology and results of developing diagnosis related groups (DRGs) for the cases of healthcare provided with the use of radiotherapy and chemoradiotherapy for malignant neoplasms in Russian Federation. A key element of the methodology is the standardized module of healthcare (SM) which allows calculating the tariffs for medical care in accordance with clinical guidelines. As a result of the application of the new methodology, in 2019, changes were made to the DRG model in terms of payment for radiotherapy and chemoradiotherapy. The changes included developing 10 DRGs for in-patient radiotherapy and 10 DRGs in day hospital; 7 DRGs for in-patient chemoradiotherapy and 5 DRGs in day hospital. New classification criteria have been introduced into the DRG model for attributing the case to a certain DRG, in addition to the medical service used before. The number of fractions became a new criterion for radiotherapy, the number of fractions and the international non-proprietary name of the drug were proposed for chemoradiotherapy. A wider range of DRG’s weight coefficients was calculated, which allows more differentiated reimbursement of the costs of medical care provided by medical organizations depending on the method and the regimen used.

About the Authors

Yu. A. Ledovskikh
The Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Russian Federation

Moscow



E. V. Semakova
he Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Russian Federation
Moscow


V. V. Omelyanovskiy
The Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Russian Federation
Moscow


A. A. Kravtsov
The Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Russian Federation
Moscow


E. A. Prokhorovich
The Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Russian Federation
Moscow


M. V. Avxentyeva
The Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation; Sechenov First Moscow State Medical University
Russian Federation
Moscow


I. A. Zheleznyakova
The Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Russian Federation
Moscow


A. V. Petrovskiy
Sechenov First Moscow State Medical University; National Medical Research Center of Oncology named after N.N. Blokhin of the Ministry of Health of Russia
Russian Federation
Moscow


References

1. RF Federal Law “On the Basics of Protecting Citizens’ Health in the Russian Federation” dated 21.11.2011 No. 323-FZ. (in Russian)

2. Avxentyeva M.V., Omelyanovskiy V.V., Petrovskiy A.V., Davydov M.I., Zheleznyakova I.A. et al. New Approaches to the Development of Diagnostic Related Groups for Cancer Pharmacotherapy in Russian Federation, Medical Technologies. Assessment and Choice, 2018, vol. 32, no. 2, pp. 8–23 (in Russian).

3. Ledovskikh Y.A., Semakova E.V., Omelyanovskiy V.V. Methodology for the development of diagnosis related groups based on clinical guidelines using standardized modules of healthcare, Medical Technologies. Assessment and Choice, 2019, vol. 37, no. 3, pp. 8–15 (in Russian).

4. Order of the Ministry of Health of Russia “On approval of the procedure for developing standards of medical care” dated 02.02.2018 No. 53n. (in Russian)

5. Order of the Ministry of Health of Russia “On approval of the procedure for the provision of medical care to the patients with oncological deseases” dated 15.11.2012 No. 915n. (in Russian)

6. Order of the Ministry of Health of the Russian Federation “On approval of the nomenclature of medical services” dated 13.10.2017 No. 804n. (in Russian)

7. State register of maximum selling prices. Available at: https://grls. rosminzdrav.ru/pricelims.aspx (accessed 05.05.2019). (in Russian)

8. Malignant neoplasms in Russia in 2017 (morbidity and mortality), by Kaprin A.D., Starinsky V.V., Petrova G.V. as eds. Moscow, MNIOI after P.A. Herzen – a branch of the Federal State Budgetary Institution «NMIRTS» of the Ministry of Health of the Russian Federation Publ., 2018. 250 p. (in Russian)

9. Letter dated 11.21.2018 of the Ministry of Health of the Russian Federation No. 11–7/10/2–7543 and of the Federal Compulsory Medical Insurance Fund No. 14525/26–1/i “On methodological recommendations on methods of paying for medical care financed by compalsory medical insurance”. (in Russian)

10. Afregning og finansiering (DRG). Available at: https://sundhedsdatastyrelsen.dk/da/afregning-og-finansiering (accessed 12.05.2019).

11. Glocker S., Loskamp N., Bamberg M., Roder N. Evaluation von Fallpauschalen in der Radioonkologie, Strahlentherapie und Onkol, 2006, vol. 182, no. 6, pp. 305–311. (in Deutsch)

12. Schmidberger H. Reimbursement of radiotherapy in Germany, Cancer/Radiothérapie, 2017, vol. 21, no. 6–7, pp. 544–546.

13. Tan S.S., Geissler A., Serdén L., Heurgren M., van Ineveld B.M., Redekop W.K., Hakkaart-van Roijen L., Eur. J. Public Health, 2014, vol. 24, no. 6, pp. 1023–1028.


Review

For citations:


Ledovskikh Yu.A., Semakova E.V., Omelyanovskiy V.V., Kravtsov A.A., Prokhorovich E.A., Avxentyeva M.V., Zheleznyakova I.A., Petrovskiy A.V. New approaches to formation of diagnosis-related groups for payment for radiotherapy and chemoradiotherapy based on clinical guidelines with the use of standardized modules of healthcare. Biomedical Photonics. 2019;8(4):36-46. https://doi.org/10.24931/2413-9432-2019-8-4-36-46

Views: 1321


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2413-9432 (Print)